BioWorld - Thursday, January 29, 2026

BioWorld Science

Aug. 12, 2020

View Archived Issues

After injury, astrocytes can make interneurons

Read More

First patient enrolled in study of plasma-derived IgG product as treatment of COVID-19 in Israel

Read More

CAR T cells targeting CD30 safe and active in patients with Hodgkin's lymphoma

Read More

Efficient CNS microglia replacement strategy developed

Read More

First-in-human data for anti-miR-92a therapy, MRG-110

Read More

Smoking and COPD are associated with increased ACE2 in alveolar and bronchial epithelium

Read More

SCO-094 enters phase I testing in patients with type 2 diabetes mellitus

Read More

Pivotal CheckMate-649 and CheckMate-577 studies of Opdivo meet primary endpoints

Read More

Medshine Discovery discloses new TGFBR1 inhibitors

Read More

New NLRP3 inflammasome inhibitors discovered at NodThera

Read More

Camphor Pharmaceuticals synthesizes new prostanoid EP4 receptor antagonists

Read More

FDA issues complete response letter for Pedmark

Read More

Ascentage Pharma, University of Michigan patent Mcl-1 inhibitors

Read More

5'-nucleotidase inhibitors discovered by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Read More

Interim analysis data from ReDUX4 study of losmapimod in FSHD

Read More

Arcturus initiates dosing in phase I/II study of its COVID-19 vaccine candidate

Read More

Topline data presented from phase II study of leronlimab in mild to moderate COVID-19

Read More

Low-dose IL-2 shows potential for treating children with type 1 diabetes

Read More

New phase II trial explores use of M-5049 for COVID-19 pneumonia

Read More

FDA clears IND for phase I/II study of KAHR's DSP-107 in advanced solid tumors

Read More